Logo Logo
Hilfe
Hilfe
Switch Language to English

Proebstl, Lisa; Kamp, Felicia; Manz, Kirsi ORCID logoORCID: https://orcid.org/0000-0002-7740-4076; Krause, Daniela; Adorjan, Kristina; Pogarell, Oliver; Koller, Gabi; Soyka, Michael; Falkai, Peter ORCID logoORCID: https://orcid.org/0000-0003-2873-8667 und Kambeitz, Joseph (Juni 2019): Effects of stimulant drug use on the dopaminergic system: A systematic review and meta-analysis of in vivo neuroimaging studies. In: European Psychiatry, Bd. 59: S. 15-24

Volltext auf 'Open Access LMU' nicht verfügbar.

Abstract

Background Stimulant drugs can cause persistent changes in the brain. Imaging studies show that these changes are most apparent in dopamine transporter (DAT) or receptor availability within the striatum.

Methods This work focuses on influences of stimulant use on dopaminergic function assessed using nuclear-medicine imaging (PET/SPECT). Included are 39 studies on 655 cocaine, amphetamine, methamphetamine or nicotine users, as well as 690 healthy controls. Metaanalyses were conducted separately for D2/D3 receptors and dopamine transporters of the entire striatum, its subregions caudate and putamen respectively.

Results Meta-analyses results regarding nicotine did not show significant effects between smokers and nonsmokers. In cocaine users there was a significant decrease in dopamine receptor availability in all regions. The striatal DAT availability was significantly increased in cocaine users. Methamphetamine users showed a significantly decreased dopamine receptor and transporter density in all regions. Significant results also indicate a lower transporter availability in all regions. Amphetamine users showed reduced DAT availability in the striatum, as well as in the sub regions.

Conclusion This meta-analysis provides evidence that there are ongoing changes in the dopaminergic system associated with the use of stimulants. Especially the results of cocaine, methamphetamine and amphetamine use mainly showed a downregulation. In addition, this meta-analysis is the first to include nicotine. This subset of studies showed evidence for a decreased receptor and DAT availability but no significant results were found in the metaanalyses.

Dokument bearbeiten Dokument bearbeiten